ABSK021

· Abbisko Therapeutics Co, Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABSK021, covering 2024-08-12 to 2024-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Effect of Itraconazole and Rifampicin on ABSK021 [Phase 1]